Dose‐dependent inhibition of demyelination and microglia activation by IVIG

OBJECTIVE: Intravenous immunoglobulin (IVIG) is an established treatment for numerous autoimmune conditions. Clinical trials of IVIG for multiple sclerosis, using diverse dose regimens, yielded controversial results. The aim of this study is to dissect IVIG effector mechanisms on demyelination in an...

Descripción completa

Detalles Bibliográficos
Autores principales: Winter, Meike, Baksmeier, Christine, Steckel, Julia, Barman, Sumanta, Malviya, Manish, Harrer‐Kuster, Melanie, Hartung, Hans‐Peter, Goebels, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099529/
https://www.ncbi.nlm.nih.gov/pubmed/27844029
http://dx.doi.org/10.1002/acn3.326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099529/
https://www.ncbi.nlm.nih.gov/pubmed/27844029
http://dx.doi.org/10.1002/acn3.326

Ejemplares similares